MA H1972

Bill

To permit the wholesale importation of prescription drugs into the Commonwealth

Introduced
01/22/2019

In Committee
01/22/2019

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

Relative to the wholesale importation of prescription drugs into the Commonwealth. Public Health.

AI Summary

This bill aims to establish a state-administered wholesale importation program for prescription drugs in the Commonwealth. The program would allow the state to import safe and cost-effective prescription drugs from regulated Canadian suppliers, solely for distribution to participating in-state pharmacies and healthcare providers. The bill outlines various requirements, such as ensuring drug safety, tracking and tracing, preventing distribution outside the state, and limiting profit margins. The Department of Health and Human Services would be responsible for designing the program, seeking federal approval, and implementing it once funding is secured. The Department would also be required to report biannually on the program's operation, including the drugs included, participation numbers, and estimated savings.

Committee Categories

Health and Social Services

Sponsors (4)

Brian Ashe (D), Mike Day (D), Leonard Mirra (R), Matt Muratore (R),

Last Action

Accompanied a study order, see H4449 (on 02/24/2020)

Official Document

https://malegislature.gov/Bills/191/H1972

(16 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://malegislature.gov/Bills/191/H1972
Bill	https://malegislature.gov/Bills/191/H1972.pdf

Bill	Bill Name	Last Action	Type
H1162	To promote transparency in prescription drug prices	Reporting date extended to Thursday December 31, 2020, pending concurrence	Similar To
H1167	Relative to prescription drug price transparency	Reporting date extended to Thursday December 31, 2020, pending concurrence	Similar To
H1860	Relative to the dispensing of prescription drugs	Reporting date extended to Thursday December 31, 2020, pending concurrence	Similar To
H1913	Authorizing a 90-day supply of medically necessary testosterone therapy medication	Accompanied a study order, see H4449	Similar To
H4449	Public health matters	Reported, in part, by H1886	Replaced by
H755	Relative to the importation of animals for rescue, shelter, foster, adoption or remote sale	Accompanied a study order, see H5071	Similar To
H898	Relative to consumer deductibles	Accompanied a study order, see H5160	Similar To
H916	Relative to co-pay assistance	Accompanied a study order, see H5160	Similar To
S1149	Strengthening prescription drug safety and drug stewardship	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To
S1277	Relative to the prescription monitoring program	Accompanied a study order, see S2683	Similar To
S2397	Relative to pharmaceutical access, costs and transparency	Reprinted as amended, see S2409	Similar To
S2409	Relative to pharmaceutical access, costs and transparency	Read; and referred to the committee on House Ways and Means	Similar To
S552	To promote transparency in prescription drug prices	Accompanied a study order, see S2543	Similar To
S570	Relative to out-of-pocket expenses for prescription drug coverage	Accompanied a study order, see S2543	Similar To
S582	Ensuring access to medications	Accompanied a study order, see S2543	Similar To
S721	Relative to mandatory prescription drug coverage	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To

Bill

Bill Name

Last Action

Type

H1162

To promote transparency in prescription drug prices

Reporting date extended to Thursday December 31, 2020, pending concurrence

Similar To

H1167

Relative to prescription drug price transparency

Reporting date extended to Thursday December 31, 2020, pending concurrence

Similar To

H1860

Relative to the dispensing of prescription drugs

Reporting date extended to Thursday December 31, 2020, pending concurrence

Similar To

H1913

Authorizing a 90-day supply of medically necessary testosterone therapy medication

Accompanied a study order, see H4449

Similar To

H4449

Public health matters

Reported, in part, by H1886

Replaced by

H755

Relative to the importation of animals for rescue, shelter, foster, adoption or remote sale

Accompanied a study order, see H5071

Similar To

H898

Relative to consumer deductibles

Accompanied a study order, see H5160

Similar To

H916

Relative to co-pay assistance

Accompanied a study order, see H5160

Similar To

S1149

Strengthening prescription drug safety and drug stewardship

Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session

Similar To

S1277

Relative to the prescription monitoring program

Accompanied a study order, see S2683

Similar To

S2397

Relative to pharmaceutical access, costs and transparency

Reprinted as amended, see S2409

Similar To

S2409

Relative to pharmaceutical access, costs and transparency

Read; and referred to the committee on House Ways and Means

Similar To

S552

To promote transparency in prescription drug prices

Accompanied a study order, see S2543

Similar To

S570

Relative to out-of-pocket expenses for prescription drug coverage

Accompanied a study order, see S2543

Similar To

S582

Ensuring access to medications

Accompanied a study order, see S2543

Similar To

S721

Relative to mandatory prescription drug coverage

Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session

Similar To

Bill > H1972

MA H1972

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (4)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary